Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Bacterial Vaginosis
Open-data reference.
15 US clinical trials · 3 currently recruiting
Active & Recent Trials
Prospective Data Bank Creation to Study Vaginal Conditions
Texas Tech University Health Sciences Center
NCT01829204
Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
Queen's Medical Center
NCT05753813
Clinical Protocol CERN Feasibility Study
Cern Corporation
NCT06933420
Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs
Rush University Medical Center
NCT05666778
Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis
Balmoral Medical company
NCT03091777
Performance Study of the Cobas® BV/CV Test on Samples From Participants With and Without Symptoms of Bacterial Vaginosis and Candida Vaginitis
Hoffmann-La Roche
NCT06975436
Treatment of Bacterial Vaginosis (BV) With Tinidazole
University of Alabama at Birmingham
NCT00334633
A Validation Study of Genzyme Diagnostics OSOM Trichomonas Rapid Test and BVBlue Test
University of Pittsburgh
NCT00682851
Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women
National Institute of Allergy and Infectious Diseases (NIAID)
NCT01230814
LACTIN-V Study for Recurrent Bacterial Vaginosis
National Institute of Allergy and Infectious Diseases (NIAID)
NCT02766023
Vitamin D and Sexual Health
Ohio State University
NCT01450462
Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity
University of Washington
NCT02432404
Suppression Of Bacterial Vaginosis (BV) [SUBVert]
National Institute of Allergy and Infectious Diseases (NIAID)
NCT03930745
Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study
University of Pittsburgh
NCT00464542
Flourish HEC to Prevent Recurrence of BV
Vaginal Biome Science
NCT05386147
Phase Distribution
| Phase | Trial count |
|---|---|
| Early Phase 1 | 1 |
| Phase 2 | 4 |
| Phase 3 | 1 |
| Phase 4 | 3 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Bacterial Vaginosis Trial Landscape
ClinicalTrials.gov lists 15 US studies indexed under Bacterial Vaginosis, and 3 of those are currently open to recruitment — roughly 20% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Bacterial Vaginosis shows 4 late-stage studies (Phase 3 and Phase 4 combined) alongside 5 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Bacterial Vaginosis is led by National Institute of Allergy and Infectious Diseases (NIAID) with 3 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 15 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Bacterial Vaginosis?
PlainTrial tracks 15 US clinical trials for Bacterial Vaginosis, of which 3 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Bacterial Vaginosis?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.